BMY
Bristol-Myers Squibb CompanyData updated: 2026-06-05 · Current price: $57.27
Composite Score: 75
BUY
Score: 75 / 100
Strong fundamentals and attractive valuation — consider buying opportunities
Profitability
60
Growth
51
Valuation
100
Moat
30
Stability
70
Business Quality
ROE · Gross Margin · Revenue Growth
ROE
38.2%
Quality threshold: > 15%
Gross Margin
71.1%
Quality threshold: > 40%
Rev. Growth (5yr)
1.0%
Quality threshold: > 5%
5-Year ROE: 38.2% → -54.8% → 27.3% → 20.4% → 19.5%|5-Year Gross Margin: 71.1% → 71.1% → 76.2% → 78.0% → 78.6%
Financial Strength
Debt Ratio · Free Cash Flow · Current Ratio
Debt / Equity
3.87
Quality threshold: < 0.5
FCF (5yr avg)
15.7B $
Quality threshold: > 0
Current Ratio
1.26x
Quality threshold: > 1.5
FCF Trend (B USD)
$15.5B2022
$16.4B2023
$15.1B2024
$14.2B2025
$17.2B2026
Valuation
Intrinsic Value · Margin of Safety
Owner Earnings
$9.8B
Net Income + D&A - CapEx
Current Price
$57.27
Source: Alpha Vantage
💡 Valuation Note: Intrinsic value based on DCF model, adjustable above. Visit the DCF Calculator for full three-stage valuation.
Complete Your Analysis
"Price is what you pay. Value is what you get."
— Warren Buffett